118 related articles for article (PubMed ID: 20198330)
1. The antitumor effect of PLK1 and HSF1 double knockdown on human oral carcinoma cells.
Kim SA; Kwon SM; Yoon JH; Ahn SG
Int J Oncol; 2010 Apr; 36(4):867-72. PubMed ID: 20198330
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of polo-like kinase 1 promotes hyperthermia sensitivity via inactivation of heat shock transcription factor 1 in human retinoblastoma cells.
Yunoki T; Tabuchi Y; Hayashi A; Kondo T
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8353-63. PubMed ID: 24366665
[TBL] [Abstract][Full Text] [Related]
3. Rapid functional screening of effective siRNAs against Plk1 and its growth inhibitory effects in laryngeal carcinoma cells.
Lan H; Zhu J; Ai Q; Yang Z; Ji Y; Hong S; Song F; Bu Y
BMB Rep; 2010 Dec; 43(12):818-23. PubMed ID: 21189159
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells.
Tyagi S; Bhui K; Singh R; Singh M; Raisuddin S; Shukla Y
Biochem Pharmacol; 2010 Nov; 80(9):1326-34. PubMed ID: 20655883
[TBL] [Abstract][Full Text] [Related]
7. TPX2 promotes cell proliferation and migration via PLK1 in OC.
Ma S; Rong X; Gao F; Yang Y; Wei L
Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
[TBL] [Abstract][Full Text] [Related]
8. HSF1 as a mitotic regulator: phosphorylation of HSF1 by Plk1 is essential for mitotic progression.
Lee YJ; Kim EH; Lee JS; Jeoung D; Bae S; Kwon SH; Lee YS
Cancer Res; 2008 Sep; 68(18):7550-60. PubMed ID: 18794143
[TBL] [Abstract][Full Text] [Related]
9. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase 1 phosphorylates heat shock transcription factor 1 and mediates its nuclear translocation during heat stress.
Kim SA; Yoon JH; Lee SH; Ahn SG
J Biol Chem; 2005 Apr; 280(13):12653-7. PubMed ID: 15661742
[TBL] [Abstract][Full Text] [Related]
11. PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins.
Zuco V; De Cesare M; Zaffaroni N; Lanzi C; Cassinelli G
Oncotarget; 2015 Apr; 6(11):8736-49. PubMed ID: 25826089
[TBL] [Abstract][Full Text] [Related]
12. Heat shock factor 1-mediated aneuploidy requires a defective function of p53.
Kim EH; Lee YJ; Bae S; Lee JS; Kim J; Lee YS
Cancer Res; 2009 Dec; 69(24):9404-12. PubMed ID: 19934326
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
[TBL] [Abstract][Full Text] [Related]
14. Normal cells, but not cancer cells, survive severe Plk1 depletion.
Liu X; Lei M; Erikson RL
Mol Cell Biol; 2006 Mar; 26(6):2093-108. PubMed ID: 16507989
[TBL] [Abstract][Full Text] [Related]
15. Phospho‑regulation of Cdc14A by polo‑like kinase 1 is involved in β‑cell function and cell cycle regulation.
Hu H; Shao D; Wang L; He F; Huang X; Lu Y; Xiang X; Zhu S; Zhang P; Li J; Chen J
Mol Med Rep; 2019 Nov; 20(5):4277-4284. PubMed ID: 31545409
[TBL] [Abstract][Full Text] [Related]
16. Study on the effect of IRE1a on cell growth and apoptosis via modulation PLK1 in ER stress response.
Li X; Zhu H; Huang H; Jiang R; Zhao W; Liu Y; Zhou J; Guo FJ
Mol Cell Biochem; 2012 Jun; 365(1-2):99-108. PubMed ID: 22314839
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.
Zhao C; Gong L; Li W; Chen L
J Cancer Res Clin Oncol; 2010 Jan; 136(1):9-16. PubMed ID: 19572149
[TBL] [Abstract][Full Text] [Related]
18. Plk1 regulates liver tumor cell death by phosphorylation of TAp63.
Komatsu S; Takenobu H; Ozaki T; Ando K; Koida N; Suenaga Y; Ichikawa T; Hishiki T; Chiba T; Iwama A; Yoshida H; Ohnuma N; Nakagawara A; Kamijo T
Oncogene; 2009 Oct; 28(41):3631-41. PubMed ID: 19668228
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
[TBL] [Abstract][Full Text] [Related]
20. Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication.
Wang WH; Studach LL; Andrisani OM
Hepatology; 2011 Apr; 53(4):1137-47. PubMed ID: 21480320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]